Global Rare Disease Drugs Market Report 2022: Market Value to Double in Just 5 Years, from $161 Billion in 2022 to $326 Billion in 2027
06 déc. 2022 07h18 HE
|
Research and Markets
Dublin, Dec. 06, 2022 (GLOBE NEWSWIRE) -- The "Global Rare Disease Drugs Market (2022 Edition) - Analysis By Drug Type, Therapeutic Area, Patients, Route of Administration, Distribution Channel, By...
Global Pharmacy Benefit Management Market Analysis Report 2022: A $685 Billion Industry in 2026 - Long-term Forecast to 21031
14 nov. 2022 05h06 HE
|
Research and Markets
Dublin, Nov. 14, 2022 (GLOBE NEWSWIRE) -- The "Pharmacy Benefit Management Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global pharmacy benefit...
Signature Healthcare Partners With Clearway Health to Expand Community Access With Retail Pharmacy
08 nov. 2022 08h00 HE
|
Clearway Health
BOSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Signature Healthcare patients and the surrounding community are enjoying convenient access to affordable prescriptions at the new pharmacy located at 110...
Medication Adherence Global Market Report 2022: Featuring Koninklijke Philips, Johnson & Johnson, Qualcomm, MedMinder & More
02 nov. 2022 09h38 HE
|
Research and Markets
Dublin, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The "Medication Adherence Global Market Report 2022, By Type, By Medication, By Application" report has been added to ResearchAndMarkets.com's offering. ...
$64 Billion Worldwide Gynecology Drugs Industry to 2031 - Rising Investment to Understand the Mechanisms of Endometriosis and its Treatment is Driving Growth
04 oct. 2022 04h58 HE
|
Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- vThe "Gynecology Drugs Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...
TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr. Jeff Newell, For its Board of Directors
03 oct. 2022 09h15 HE
|
Trxade Health, Inc.
TAMPA, FL, Oct. 03, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by...
Pharmaceutical Drugs Global Market Report 2022: Changing from Products from Prescription to OTC Presents Opportunities for Further Growth
28 sept. 2022 07h28 HE
|
Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Drugs Global Market Report 2022: By Type, By Distribution, By Route, By Drug, By Mode" report has been added to ...
Automatic Pill Dispenser Machine Market Report 2022: Integration of AI Presents Lucrative Opportunities
09 sept. 2022 07h43 HE
|
Research and Markets
Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Automatic Pill Dispenser Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Radiodermatitis Market to Rise at a CAGR of 3.3% during Forecast Period, observes TMR Study
08 sept. 2022 10h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - According to insights on the radiodermatitis market, in 2018, the global radiodermatitis...
Global Radiodermatitis Market Anticipated to Generate a Revenue of $561.7 Million and Rise at a CAGR of 4.1% during the Forecast Timeframe 2021-2028 | Approved [169-Pages] by Research Dive
29 août 2022 09h08 HE
|
Research Dive
New York, USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global radiodermatitis market is envisioned to garner a revenue of $561.7 million and grow at a...